Mumbai platform to support India’s journey toward self-reliance with focused sectors: APIs, KSMs, formulations, and excipients
MUMBAI, INDIA: Messe Muenchen India, in collaboration with the Indian Drug Manufacturers’ Association (IDMA), has announced PharmaCore India 2026, a dedicated trade fair focused on strengthening India’s pharmaceutical sector.
📅 Dates: 22–24 April 2026
📍 Venue: Jio Convention Centre, Mumbai
The event will serve as West India’s only strategic marketplace for critical pharmaceutical segments — APIs, formulations, chemicals, and excipients.
Organizers
- Messe Muenchen India (MMI): A leading organizer of trade fairs and B2B events.
- Indian Drug Manufacturers’ Association (IDMA): Apex body representing India’s pharma manufacturers and a longstanding advocate for local pharmaceutical growth.
Together, they aim to foster collaboration, innovation, and supply chain resilience in India’s pharma ecosystem.
Industry Context
India is widely recognized as the “pharmacy of the world”. However, challenges remain in building domestic KSM and API capabilities to reduce import dependence.
PharmaCore India 2026 is positioned to complement the industry landscape by:
- Driving dialogue and collaboration.
- Strengthening supply chains.
- Encouraging innovation in pharma manufacturing.
Leadership Insights
Bharat N Shah, National President, IDMA:
“PharmaCore India is a step towards addressing some of the sector’s priorities. By focusing on KSMs, APIs, formulations, and excipients, our aim is to provide members and stakeholders with an opportunity to strengthen supply chains, foster innovation, and exchange knowledge to support industry growth.”
Bhupinder Singh, President IMEA & CEO, Messe Muenchen India:
“PharmaCore India, in collaboration with IDMA, is designed to create an open and collaborative environment for West India’s pharmaceutical sector. By bringing together leading manufacturers, innovators, and stakeholders, we aim to foster regional progress in APIs, formulations, and chemical inputs — facilitating industry partnerships, supporting shared growth, and advancing the sector in meaningful ways.”
Key Highlights of PharmaCore India 2026
- Focused Showcase: Dedicated to KSMs, APIs, formulations, and excipients — the backbone of pharma manufacturing.
- Investment & Innovation Hub: Investor–Startup Forum connecting innovators, ingredient specialists, and investors.
- Strategic Location: Mumbai — India’s nerve centre for pharmaceutical corporates, regulators, and exporters.
- Global Gateway: Platform to forge international sourcing, trade partnerships, and supply chain collaborations.
- Co-located with analytica Lab India: South Asia’s biggest laboratory and analytical technology fair, enabling attendees to access both pharmaceutical and laboratory industry communities at a single venue.
Objective
PharmaCore India 2026 aims to build a resilient, integrated, and innovation-driven pharma ecosystem in India by:
- Addressing supply chain gaps.
- Fostering collaboration.
- Enabling sustainable growth.
About Messe Muenchen India
Established in 2007 as a wholly owned subsidiary of Messe München GmbH, Messe Muenchen India is one of the leading B2B trade fair organizers in the IMEA region.
Its portfolio includes bauma CONEXPO INDIA, electronica India, productronica India, IFAT India, analytica Lab India, Pharma Pro&Pack Expo, drinktec India, Indian Ceramics Asia, World Tea & Coffee Expo, and more.
With its expansive reach and strong networks, Messe Muenchen India enables business growth, investment, innovation, and cross-border collaboration across dynamic markets.
About the Indian Drug Manufacturers’ Association (IDMA)
Founded in 1961, IDMA is the apex national body representing over 1,000 pharmaceutical and API manufacturers across India.
Widely regarded as the “Voice of the National Sector”, IDMA collaborates with the Government of India on:
- Pricing, policy, and regulatory affairs.
- Promoting affordable, high-quality medicines.
- Training programs, workshops, and global quality compliance initiatives.
- Encouraging R&D, innovation, and IPR awareness.
- Supporting CSR initiatives.
IDMA continues to play a pivotal role in advancing India’s pharma sector and reinforcing its position as the pharmacy of the world.
